All In Biotech

Drug Trial Radar · NCT06819735

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

A Phase 1/2, Multicentre, Open-label Clinical Trial of DT-7012 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Participants With Selected Advanced Solid Tumors (DOMISOL, DOmain_therapeutics Monoclonal antIbody for SOLid Tumors)

Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

125

Planned (sponsor's estimate)

Start

Jun 25, 2025

Primary completion

Sep 2027

Study completion Jan 2028

Sponsor

Sponsor type
Industry
Collaborators
Domain Therapeutics SA
First posted
Feb 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 1/2, dose-escalation, clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of DT-7012 (an anti-CCR8 monoclonal antibody) as a single agent and in combination with an immune checkpoint inhibitor in adult participants with selected advanced solid tumors.

Conditions

  • Advanced Solid Tumors

Interventions

  • DT-7012Drug

    Intravenous infusion

  • Immune checkpoint inhibitorDrug

    Intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with DLTs, TEAEs, TRAEs, AESIs, SAEs and AEs leading to treatment discontinuationTime frame: Cycle 1 (21 days)

Locations

9 sites in 3 countries. Site status is shown where the registry gives one.

  • Honor Health Research Institute

    Scottsdale, Arizona · Not yet recruiting

  • Macquarie University Clinical Trial Unit

    North Ryde, New South Wales, Australia · Recruiting

  • Cancer Research SA

    Adelaide, South Australia, Australia · Recruiting

  • Peninsula & South Eastern Haematology & Oncology Group

    Frankston, Victoria, Australia · Recruiting

  • Cabrini Health Limited

    Malvern, Victoria, Australia · Recruiting

  • One Clinical Research Pty Ltd

    Nedlands, Western Australia, Australia · Recruiting

  • Institut Bergonié

    Bordeaux, France · Recruiting

  • Hôpitaux Universitaires de Strasbourg

    Strasbourg, France · Recruiting

  • Institut Gustave Roussy

    Villejuif, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.